Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

Part of paid clinical trials in Macon, Georgia.

Sponsor
Nurix Therapeutics, Inc.
Study ID
NCT07516093
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • NX-5948 — DRUG
    Administered orally once daily
  • Pirtobrutinib — DRUG
    Administered orally once daily per prescribing information

Study Details

The study will evaluate the efficacy and safety of NX-5948 (bexobrutideg) versus pirtobrutinib in participants with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who are relapsed or refractory to prior covalent Bruton tyrosine kinase inhibitor (cBTKi) treatment.

Key Dates

First listed
Apr 7, 2026
Start date
Aug 3, 2026
Status verified
Aug 2026
Primary completion
Oct 31, 2029
Completion
Aug 31, 2033

Study Design

Enrollment
620 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Arm A: NX-5948
  • Experimental: Arm B: Pirtobrutinib

Primary Outcome Measure

Progression-free survival (PFS) as assessed by Independent Review Committee (IRC) [ Time Frame: Up to approximately 3.5 years ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
Central Georgia Cancer CareMaconGeorgia31210-
Fort Wayne Medical Oncology and HematologyFort WayneIndiana46804-
Hematology Oncology of IndianaIndianapolisIndiana46260-
SCRI Oncology PartnersNashvilleTennessee37203-
Texas Oncology - West TexasMidlandTexas79124-
Virginia Cancer SpecialistsFairfaxVirginia22201-

Find similar trials in Macon, GA

Nationwide
Leukemia (other) trialsOncology trialsBlood cancer trials
By condition
Leukemia (other)
By specialty
OncologyBlood cancer
By research site
Central Georgia Cancer Care· Macon, GAFort Wayne Medical Oncology and Hematology· Fort Wayne, INHematology Oncology of Indiana· Indianapolis, INSCRI Oncology Partners· Nashville, TNTexas Oncology - West Texas· Midland, TXVirginia Cancer Specialists· Fairfax, VA

Related Studies